Depakote ER Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Divalproex sodium (Depakote ER) 250 mg extended-release tablets: White ovaloid tablets with the corporate logo and the Abbo-code HF.
Divalproex sodium (Depakote ER) 500 mg extended-release tablets: Gray ovaloid tablets with the corporate logo and the Abbo-Code HC.
Divalproex sodium (Depakote ER) extended-release tablets contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 mg and 500 mg of valproic acid.
Excipients with known effect: Divalproex sodium (Depakote ER) 250 mg extended-release tablets: The coating of the tablet contains Lactose.
Divalproex sodium (Depakote ER) 500 mg extended-release tablets: This medicine contains Lactose.

valproic acid

Manufacturer:

Abbott

Distributor:

Abbott